Cardiology
Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
Published in Healthcare Finance, Tax and Law Weekly, July 25th, 2007
Since the May 2007 release of a New England Journal of Medicine (NEJM) report that Avandia users are 43 percent more likely to suffer a heart attack and 67 percent more likely to die of cardiovascular causes than non-users of Avandia, it is no surprise that physicians intend to switch many type 2 diabetes patients from Avandia to therapies believed to pose less risk. Research from GfK Market Measures' Event Flash, Physicians' Reactions to NEJM's Results on Avandia's Increased CV Risk, suggests, however, a greater negative response by internists than endocrinologists.
The GfK Market Measures study showed universal awareness of the NEJM report, though not all physicians...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- AcroMetrix Corporation
AcroMetrix Expands to a New State-of-the-Art Facility - Allion Healthcare, Inc.
Allion Healthcare Announces Planned Departure of CFO Jim Spencer - Allsup Inc.
Allsup Examines Impact of Social Security Taxes on Disabled and their Families - American Council of Life Insurers
ACLI Annual Conference Will Bring Life Insurance Industry Leaders to Washington, D.C. This Fall - American Life League
Law Evicts Planned Parenthood From Schools; a Noteworthy Victory for Parents in Missouri - Amistaff Healthcare Technology, Inc.
Amistaff Healthcare Technology, Inc. Announces a New Exam Validation Process to Improve the Quality of Patient Care - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
